A detailed history of Bvf Inc transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Bvf Inc holds 21,751,284 shares of MLTX stock, worth $1.04 Billion. This represents 29.25% of its overall portfolio holdings.

Number of Shares
21,751,284
Previous 21,751,284 -0.0%
Holding current value
$1.04 Billion
Previous $1.09 Billion 12.46%
% of portfolio
29.25%
Previous 32.73%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$4.69 - $13.25 $102 Million - $288 Million
21,751,284 New
21,751,284 $114 Million

Others Institutions Holding MLTX

About MoonLake Immunotherapeutics


  • Ticker MLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,925,600
  • Market Cap $1.77B
  • Description
  • MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...
More about MLTX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.